Stay updated on Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor update to the page metadata or content. It does not alter the study details or eligibility information.
    Difference
    0.0%
    Check dated 2026-06-08T03:56:07.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, reflecting a minor update to the page's version metadata.
    Difference
    0.0%
    Check dated 2026-05-17T09:08:50.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, reflecting a minor platform/version change without altering the displayed trial details.
    Difference
    0.0%
    Check dated 2026-04-25T18:25:24.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.0.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:17:51.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Location entry updated from Napoli, Italy, 80123 to Naples, Italy, 80123. Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T19:51:48.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:20:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.